Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Trinity College Develops Gene Therapy for Glaucoma and AMD
A team of researchers at Trinity College Dublin has developed a gene therapy that shows promise for treating both glaucoma and dry age-related macular degeneration (AMD). The therapy, which uses an enhanced gene (eNdi1) delivered by an approved virus, aims…
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation – CU Anschutz newsroom
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…
Dangers of Eye Color-Changing Drops: Ophthalmologists Warn
The American Academy of Ophthalmology is warning the public about over-the-counter eye drops that claim to change eye color. These products, popularized on social media platforms like TikTok, are unproven, unregulated, and could pose significant risks to eye health. Unapproved…
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…
AMD Explained: Tips for Safeguarding Your Vision
The eyes are often called the windows to the soul, but what happens when those windows become cloudy and blurred? That’s the reality for millions suffering from age-related macular degeneration (AMD), which can rob you of your precious eyesight as…
European Commission Approves Roche’s Vabysmo for RVO
The European Commission has approved Roche’s Vabysmo® (faricimab) for the treatment of macular edema secondary to retinal vein occlusion (RVO), including both branch and central retinal vein occlusion (BRVO and CRVO). This approval is a significant milestone, making Vabysmo the…
LENSAR Receives EU Certification for ALLY®
First EU ALLY Commercial Installation Expected in August 2024 ORLANDO, Fla.—LENSAR, Inc. (Nasdaq: LNSR), a global medical technology company specializing in advanced laser solutions for cataract treatment, announced that the ALLY Adaptive Cataract Treatment System has achieved certification under the…
What’s in Store for ESCRS 2024? Workshops, Labs, and More
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for its 42nd Annual Congress with a rich lineup of initiatives designed to enhance learning, foster collaboration, and celebrate advancements in ophthalmology. This year’s event will feature a…
Exclusive: Key Events at ESCRS 2024
The 42nd of the European Society of Cataract and Refractive Surgeons (ESCRS) is poised to offer a dynamic array of events and initiatives in 2024, featuring a mix of educational programs, commemorative milestones, and new insights into key areas of…